BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26097984)

  • 1. A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers.
    Björnsson MA; Norberg Å; Kalman S; Simonsson USH
    Anesth Analg; 2015 Oct; 121(4):904-913. PubMed ID: 26097984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Human Study of the Investigational Sedative and Anesthetic Drug AZD3043: A Dose-Escalation Trial to Assess the Safety, Pharmacokinetics, and Efficacy of a 30-Minute Infusion in Healthy Male Volunteers.
    Kalman S; Koch P; Ahlén K; Kanes SJ; Barassin S; Björnsson MA; Norberg Å
    Anesth Analg; 2015 Oct; 121(4):885-893. PubMed ID: 26111262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers.
    Norberg Å; Koch P; Kanes SJ; Björnsson MA; Barassin S; Ahlén K; Kalman S
    Anesth Analg; 2015 Oct; 121(4):894-903. PubMed ID: 26097986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone Administered as a Bolus Intravenous Injection of Phaxan in a Phase 1 Randomized Trial.
    Goodchild CS; Serrao JM; Sear JW; Anderson BJ
    Anesth Analg; 2020 Mar; 130(3):704-714. PubMed ID: 31124836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers.
    Hering WJ; Ihmsen H; Langer H; Uhrlau C; Dinkel M; Geisslinger G; Schüttler J
    Anesthesiology; 1996 Dec; 85(6):1290-9. PubMed ID: 8968176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do epoch lengths of hypnotic depth indicators affect estimated of blood-brain equilibration rate constants of propofol?
    Kim KM; Park S; Kang BJ; Choi BM; Noh GJ; Bang JY
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):305-317. PubMed ID: 33415524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and dynamics of lorazepam during and after continuous intravenous infusion.
    Greenblatt DJ; von Moltke LL; Ehrenberg BL; Harmatz JS; Corbett KE; Wallace DW; Shader RI
    Crit Care Med; 2000 Aug; 28(8):2750-7. PubMed ID: 10966246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine pharmacokinetic-pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation.
    Colin PJ; Hannivoort LN; Eleveld DJ; Reyntjens KMEM; Absalom AR; Vereecke HEM; Struys MMRF
    Br J Anaesth; 2017 Aug; 119(2):200-210. PubMed ID: 28854538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects.
    Doufas AG; Orhan-Sungur M; Komatsu R; Lauber R; Akca O; Shafer SL; Sessler DI
    Anesth Analg; 2013 Feb; 116(2):319-26. PubMed ID: 23302977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
    Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
    Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
    Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
    Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
    Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
    Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
    Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients.
    Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A
    J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial and venous pharmacokinetics of morphine-6-glucuronide and impact of sample site on pharmacodynamic parameter estimates.
    Olofsen E; Mooren R; van Dorp E; Aarts L; Smith T; den Hartigh J; Dahan A; Sarton E
    Anesth Analg; 2010 Sep; 111(3):626-32. PubMed ID: 20547824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.